Coign Capital Advisors LLC

SEC CIK: 0002056441
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Coign Capital Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2024

Holdings of REGN by Coign Capital Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−777−100.0%	Sold out	Holders
Q2 2025	777	$407.9K	0.3%	+28+3.7%	Added	Holders
Q1 2025	749	$475.0K	0.4%	+70+10.3%	Added	Holders
Q4 2024	679	$483.7K	0.4%	–	No prior filing	Holders